GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Athanase Innovation AB (OSTO:ATIN) » Definitions » Cash Flow from Financing

Athanase Innovation AB (OSTO:ATIN) Cash Flow from Financing : kr-21.02 Mil (TTM As of Dec. 2020)


View and export this data going back to 2017. Start your Free Trial

What is Athanase Innovation AB Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Dec. 2020, Athanase Innovation AB paid kr0.00 Mil more to buy back shares than it received from issuing new shares. It received kr0.00 Mil from issuing more debt. It paid kr0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent kr5.64 Mil paying cash dividends to shareholders. It received kr0.00 Mil on other financial activities. In all, Athanase Innovation AB spent kr5.64 Mil on financial activities for the six months ended in Dec. 2020.


Athanase Innovation AB Cash Flow from Financing Historical Data

The historical data trend for Athanase Innovation AB's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Athanase Innovation AB Cash Flow from Financing Chart

Athanase Innovation AB Annual Data
Trend Jun17 Jun18 Jun19
Cash Flow from Financing
- -15.38 -26.66

Athanase Innovation AB Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20
Cash Flow from Financing Get a 7-Day Free Trial -13.33 -13.33 -11.28 -15.38 -5.64

Athanase Innovation AB Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Athanase Innovation AB's Cash from Financing for the fiscal year that ended in Jun. 2019 is calculated as:

Athanase Innovation AB's Cash from Financing for the quarter that ended in Dec. 2020 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2020 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-21.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Athanase Innovation AB  (OSTO:ATIN) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Athanase Innovation AB's issuance of stock for the six months ended in Dec. 2020 was kr0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Athanase Innovation AB's repurchase of stock for the six months ended in Dec. 2020 was kr0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Athanase Innovation AB's net issuance of debt for the six months ended in Dec. 2020 was kr0.00 Mil. Athanase Innovation AB received kr0.00 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Athanase Innovation AB's net issuance of preferred for the six months ended in Dec. 2020 was kr0.00 Mil. Athanase Innovation AB paid kr0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Athanase Innovation AB's cash flow for dividends for the six months ended in Dec. 2020 was kr-5.64 Mil. Athanase Innovation AB spent kr5.64 Mil paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Athanase Innovation AB's other financing for the six months ended in Dec. 2020 was kr0.00 Mil. Athanase Innovation AB received kr0.00 Mil on other financial activities.


Athanase Innovation AB Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Athanase Innovation AB's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Athanase Innovation AB (OSTO:ATIN) Business Description

Traded in Other Exchanges
N/A
Address
Nybrogatan 3, Stockholm, SWE, 114 34
Athanase Innovation AB is an alternative investment firm with exposure to both private and public equity. It invests in innovative companies that benefit from trends such as robotics, digitalization, and automation. The principal revenue stream is initially management fees charged on the external fund capital and investment income of the underlying assets.

Athanase Innovation AB (OSTO:ATIN) Headlines

No Headlines